Targeting MTHFD2 in acute myeloid leukemia
Drugs targeting metabolism have formed the backbone of therapy for some cancers. We sought to identify new such targets in acute myeloid leukemia (AML). The one-carbon folate pathway, specifically methylenetetrahydrofolate dehydrogenase-cyclohydrolase 2 (MTHFD2), emerged as a top candidate in our an...
Main Authors: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | en_US |
Published: |
Rockefeller University Press
2022
|
Online Access: | https://hdl.handle.net/1721.1/108198.2 https://orcid.org/0000-0002-6883-3805 https://orcid.org/0000-0001-7168-8672 https://orcid.org/0000-0002-6702-4192 |